Connection

Chenjian Gu to Pandemics

Back to Details
This is a "connection" page, showing publications Chenjian Gu has written about Pandemics.
Chenjian Gu
Connection Strength
0.009
Pandemics
  1. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV. MAbs. 2021 Jan-Dec; 13(1):1953683.
    View in: PubMed
    Score: 0.002
  2. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020 11 27; 5(1):282.
    View in: PubMed
    Score: 0.002
  3. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc Natl Acad Sci U S A. 2020 11 03; 117(44):27141-27147.
    View in: PubMed
    Score: 0.002
  4. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Intern Med. 2020 10 01; 180(10):1356-1362.
    View in: PubMed
    Score: 0.002
  5. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection. Cell Rep. 2020 07 21; 32(3):107918.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.